- Home
- DINO vs CORT Comparison
DINO vs CORT Comparison
Compare DINO & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DINO | CORT |
|---|---|---|
| Founded | 1947 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 3.7B |
| IPO Year | 2022 | 2001 |
Fundamental Metrics
Financial Performance| Metric | DINO | CORT |
|---|---|---|
| Price | $56.18 | $33.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | $58.00 | ★ $105.20 |
| AVG Volume (30 Days) | ★ 3.5M | 1.7M |
| Earning Date | 05-21-2026 | 05-25-2026 |
| Dividend Yield | ★ 3.77% | N/A |
| EPS Growth | ★ 238.46 | N/A |
| EPS | ★ 3.08 | 0.82 |
| Revenue | N/A | ★ $761,407,000.00 |
| Revenue This Year | $0.07 | $29.97 |
| Revenue Next Year | $1.73 | $30.25 |
| P/E Ratio | ★ $17.24 | $40.98 |
| Revenue Growth | N/A | ★ 12.79 |
| 52 Week Low | $24.66 | $28.66 |
| 52 Week High | $59.33 | $117.33 |
Technical Indicators
Market Signals| Indicator | DINO | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 57.21 | 33.92 |
| Support Level | $47.04 | $33.53 |
| Resistance Level | $56.58 | $41.92 |
| Average True Range (ATR) | 2.36 | 1.67 |
| MACD | 0.15 | 0.24 |
| Stochastic Oscillator | 76.13 | 14.66 |
Price Performance
Historical ComparisonAbout DINO HF Sinclair Corporation
HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 300 distributors and 1,500 wholesale branded sites across 30 states. It also owns and operates 4,400 miles of petroleum product pipelines and terminals principally in the southwestern United States.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.